Chemotherapy in patients with advanced pancreatic cancer: too close to death?

Palliative chemotherapy during the last month of life

(2011) U. Nappa et al.   ANNALS OF ONCOLOGY

End-of-life care in Medicare beneficiaries dying with pancreatic cancer

(2011) Kristin M. Sheffield et al.   CANCER

Best supportive care (BSC) versus oxaliplatin, folinic acid and 5-fluorouracil (OFF) plus BSC in patients for second-line advanced pancreatic cancer: A phase III-study from the German CONKO-study group

(2011) Uwe Pelzer et al.   EUROPEAN JOURNAL OF CANCER

Development and Validation of a Prognostic Nomogram for Terminally Ill Cancer Patients

(2011) Jaime Feliu et al.   JNCI-Journal of the National Cancer Institute

FOLFIRINOX versus Gemcitabine for Metastatic Pancreatic Cancer

(2011) Thierry Conroy et al.   NEW ENGLAND JOURNAL OF MEDICINE

Cancer Statistics, 2010

(2010) A. Jemal et al.   CA-A CANCER JOURNAL FOR CLINICIANS

What Do Oncologists Say about Chemotherapy at the Very End of Life? Results from a Semiqualitative Survey

(2010) Deepti Behl et al.   JOURNAL OF PALLIATIVE MEDICINE

Use of chemotherapy at end of life in oncology patients

(2009) S. Kao et al.   ANNALS OF ONCOLOGY

Survival and Prognostic Factors of Unresectable Pancreatic Cancer

(2009) Joo Kyung Park et al.   JOURNAL OF CLINICAL GASTROENTEROLOGY

Improving the Methodologic and Ethical Validity of Best Supportive Care Studies in Oncology: Lessons From a Systematic Review

(2009) Nathan I. Cherny et al.   JOURNAL OF CLINICAL ONCOLOGY

Aggressiveness of Cancer-Care near the End-of-Life in Korea

(2008) B. Keam et al.   JAPANESE JOURNAL OF CLINICAL ONCOLOGY

CA 19-9 tumour-marker response to chemotherapy in patients with advanced pancreatic cancer enrolled in a randomised controlled trial

(2008) Viviane Hess et al.   LANCET ONCOLOGY